OMR, Euglena, and Leave a Nest produced a standard antibody against the novel coronavirus (SARS-CoV-2) and confirmed the effect in the antibody test system under joint development.
OMR Inc. has executed a Joint Research Agreement with Mitsubishi Tanabe Pharma on therapeutic antibodies for neurodegenerative diseases treatment including ALS.